Method for large-scale separation of exosome, prepared exosome and application
Through capsule filtration-TFF-PBS washing and chromatography separation, the complexity and low purity of exosome separation and purification methods were solved, and large-scale separation of high-purity exosomes and excellent anti-inflammatory and anti-inflammatory Skin repair effect.
Patent Information
- Application Number
- CN202411314970.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-20
- Publication Date
- 2024-11-08
AI Technical Summary
In the prior art, the separation and purification methods of exosomes have problems such as complex operation, small sample size, low purity, and difficult to deal with large-volume samples on a large scale. Common methods such as differential centrifugation, size exclusion chromatography and polymerization precipitation have limitations. It is difficult to obtain high purity and high yield exosomes.
Using capsule filtration-TFF-PBS filtration-chromatography separation method, multi-stage filtration and phosphate buffer PBS filtration were performed by adding trehalose to the cell supernatant, combined with tangential flow filtration and composite filler chromatography , remove large particles and small molecules of impurities to obtain high-purity exosomes.
Achieved large-scale separation of high-purity exosomes, with excellent anti-inflammatory, anti-aging and skin repair effects, and can efficiently separate and purify exosomes in large-volume cell supernatant, improving the structural clarity of exosomes and purity.
Smart Images

Figure CN118909935A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biomedical technology, and in particular relates to a method for large-scale separation of exosomes, prepared exosomes and applications. Background Art
[0002] Exosomes are a type of double-membrane vesicles released from cells to the outside of the cell, with a diameter usually ranging from 30nm to 150nm. Exosomes carry a variety of bioactive substances (such as proteins, RNA and lipids, etc.), which makes them multifunctional. They can regulate the physiological state of target cells by delivering these biomolecules, including promoting repair, anti-inflammation and immune regulation. Moreover, exosomes are relatively stable and can be stored under frozen conditions, which makes them easier to store for a long time and transport over long distances. Compared with whole cells, exosomes have lower immunogenicity, which reduces the risk of immune rejection when using exosomes, and shows unique advantages as a "cell-free cell therapy technology". Because of the unique transport characteristics of exosomes, they are also studied as drug delivery carriers, allowing them to carry specific drugs and achieve precise drug delivery through interaction with target cells. As a delivery platform, the demand for exosomes is very large, so large-scale separation and purification of exosomes is an important technology for the clinical transformation of exosomes.
[0003] Obtaining high-purity, high-yield, and standardized exosomes is a prerequisite for the widespread application of exosomes. However, there is no unified standard for the separation and purification of exosomes, which seriously restricts basic research and clinical applications related to exosomes. Currently, there are many methods for isolating exosomes, such as differential centrifugation, size exclusion chromatography, immunoseparation, and polymerization precipitation, but they all have certain limitations. Differential centrifugation is the most commonly used method. It gradually enriches exosomes through centrifugation steps at different speeds and is regarded as the "gold standard" for exosome extraction. However, it requires an expensive ultracentrifuge, is complex to operate, time-consuming, and has low yields, making it difficult to process large-volume samples on a large scale. Size exclusion chromatography fills a porous separation medium, allowing exosomes to penetrate into the pores more quickly and be separated. This method cannot separate impurities of similar size to exosomes. Immunoisolation can only specifically enrich exosomes that express one or several specific surface proteins, and requires expensive reagents such as antibodies, which is also difficult to process large-volume samples on a large scale. Exosomes obtained by the polymerization precipitation method are usually mixed with impurities such as proteins and polymers, and the activity of the exosomes cannot be guaranteed, which limits subsequent analysis. Therefore, in order to accelerate the application of exosomes, it is of great significance to develop a method for large-scale separation of high-purity exosomes.
[0004] Studies have shown that exosomes can regulate immune responses by transporting bioactive molecules and inhibit excessive inflammatory responses, thus having an anti-inflammatory effect. In addition, molecules such as growth factors and MicroRNA in exosomes can promote cell proliferation and repair, accelerate the healing process of damaged tissues, and show good repair effects. At the same time, some components in exosomes also have antioxidant and anti-aging properties, which can delay the cell aging process and maintain the health of tissues and organs. Summary of the invention
[0005] The purpose of the present invention is to provide a method for large-scale separation of high-purity exosomes, which does not rely on a centrifuge, to solve the technical problems of the prior art, such as complex operation, small sample size, low purity, and inability to be used for large-scale preparation of exosomes. In addition, the exosomes separated by the present invention have excellent anti-inflammatory, anti-aging, and skin healing effects.
[0006] The technical solution of the present invention to solve the above technical problems is as follows: A method for large-scale separation of exosomes, comprising: first adding trehalose (final concentration 2% w / v) to the harvested cell supernatant, removing large particle impurities and proteins in the cell supernatant through two-stage filtration, and then circulating the exosomes through a hollow fiber membrane with a suitable pore size and material to concentrate the exosomes, while removing small molecular protein impurities to obtain a crude exosome extract. Then, phosphate buffer PBS (containing 2% w / v trehalose) was used for displacement and filtration 5 times to further remove small molecular impurities, and then further purified by composite filler chromatography to obtain a high-purity exosome solution. Finally, the anti-inflammatory, anti-aging, and skin repair effects of exosomes were evaluated through cell experiments.
[0007] Beneficial effects of the present invention: The final exosome separation and purification method of the present invention is capsule filtration-TFF-PBS diafiltration-chromatographic separation, and the obtained exosomes have a clear structure and high purity. Compared with the exosomes separated by the common capsule filtration-TFF ultrafiltration method, the exosomes finally separated by the present invention have higher purity. In addition, the filter and hollow fiber membrane used in the present invention can be scaled up proportionally for the separation and purification of high-purity exosomes in a larger volume of cell supernatant, and the exosomes separated by this method have excellent anti-inflammatory, anti-aging and skin repair effects.
[0008] The first objective of the present invention is to provide a method for large-scale separation of exosomes to solve the technical problems of complex operation, small sample size and low purity in the prior art.
[0009] The second object of the present invention is to provide a high-purity exosome for use in the fields of reducing inflammation, anti-aging and skin repair.
[0010] In order to achieve the above-mentioned first objective, the present invention provides a method for preparing exosomes, which comprises a series of separation and purification steps including multi-stage filtration, tangential flow filtration TFF, phosphate buffer solution PBS filtration for 5 times and chromatographic separation, so as to finally obtain high-purity exosomes.
[0011] In order to achieve the above-mentioned second purpose, the present invention provides a high-purity exosome. Through cell experiments, PCR method was used to detect inflammation indicators, protein immunoblotting was used to detect type I collagen A1 levels, and scratch experiments were used to detect the repair effect of exosomes. It was found that the exosomes obtained by the present invention have excellent anti-inflammatory, anti-aging and skin repair effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 This is an electron micrograph of exosomes separated by tangential flow filtration.
[0013] Figure 2 Electron micrograph of exosomes after chromatographic separation.
[0014] Figure 3 Comparison of exosome yields in Example 1.
[0015] Figure 4 Comparison of exosome yields in Example 2.
[0016] Figure 5 Comparison of exosome yields in Example 3.
[0017] Figure 6 This is a comparison of the amount of exosome protein in Example 3.
[0018] Figure 7 This is a comparison of exosome production in Example 4.
[0019] Figure 8 The effect of different filtration times on the purity of exosomes in Example 5.
[0020] Fig. 9 The composite filler chromatography in Example 6 further improves the purity of exosomes.
[0021] Fig.10 This is the effect of exosomes on IL-1β mRNA levels in Example 8.
[0022] Fig.11 This is the HSF cell viability detection result of Example 9.
[0023] Fig.12 This is the Western Blot detection result of COL-1A1 level in HSF cells in Example 9.
[0024] Fig.13 This is the HSF cell scratch test detection in Example 10. DETAILED DESCRIPTION
[0025] Hereinafter, the technical scheme of the present invention will be clearly and completely described in conjunction with embodiments. However, the following examples are only illustrative of the present invention and are not intended to limit or restrict the scope of the present invention. Those that can be easily inferred from the detailed description and embodiments of the present invention are interpreted as falling within the scope of the present invention. In the present invention, unless otherwise specified, the methods are all conventional methods, and the raw materials can all be obtained from public commercial sources.
[0026] Example 1: Evaluation of the effect of capsule filters with different surface areas in exosome isolation.
[0027] a. 400 mL of cell supernatant was first filtered through a 1 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS100B015, 450 cm 2 ) filtration, flow rate 25mL / min.
[0028] b. The cell supernatant filtered in step a was filtered through a 0.22 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS022B015, 450 cm 2 ) was further filtered at a flow rate of 25 mL / min.
[0029] c. The cell supernatant filtered in step b was concentrated to 20-30 mL by tangential flow filtration (TFF) at a flow rate of 100 mL / min and a transmembrane pressure (TMP) of 3 psi. The hollow fiber membrane (Cobetter, HFEMI05001030P) was made of hydrophilic modified polyethersulfone (mPES) with a surface area of 94 cm 2 , the fiber inner diameter is 1 mm, the molecular weight cutoff is 500 kDa, and the obtained solution is the crude exosome extract.
[0030] d. 1μm / 0.22μm Crown capsule filter with a surface area of 450cm 2 Replaced with 200cm 2 (KG60B1PS100B010,200cm 2 / KG60B1PS022B010, 200cm 2 ), repeat steps ac to harvest the crude exosome extract.
[0031] Example 2: Evaluation of the effects of different brands of capsule filters in exosome isolation.
[0032] a. 400 mL of cell supernatant was first filtered through a 1 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS100B015) at a flow rate of 25 mL / min.
[0033] b. The cell supernatant after filtration in step a was further filtered through a 0.22 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS022B015) at a flow rate of 25 mL / min.
[0034] c. The cell supernatant filtered in step b was concentrated to 20-30 mL by TFF, with a flow rate of 100 mL / min and a transmembrane pressure (TMP) of 3 psi. The hollow fiber membrane (Cobetter, HFEMI05001030P) was made of mPES with a surface area of 94 cm 2 , the fiber inner diameter is 1 mm, the molecular weight cutoff is 500 kDa, and the obtained solution is the crude exosome extract.
[0035] d. Replace the 1μm / 0.22μm Guanou capsule filter with a 1μm / 0.22μm Cobite capsule filter, repeat steps ac, and harvest the crude exosome extract.
[0036] Example 3: Evaluation of the separation effect of hollow fiber columns with different molecular weight cut-offs in exosome separation.
[0037] a. 400 mL of cell supernatant was first filtered through a 1 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS100B015) at a flow rate of 25 mL / min.
[0038] b. The cell supernatant after filtration in step a was further filtered through a 0.22 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS022B015) at a flow rate of 25 mL / min.
[0039] c. The cell supernatant filtered in step b was concentrated to 20-30 mL by TFF, with a flow rate of 100 mL / min and a transmembrane pressure (TMP) of 3 psi. The hollow fiber membrane (Cobetter, HFEMI05001030P) was made of mPES with a surface area of 94 cm 2 , the fiber inner diameter is 1 mm, the molecular weight cutoff is 500 kDa, and the obtained solution is the crude exosome extract.
[0040] d. Replace the above-mentioned Cobetex hollow fiber column with 750 kDa (Cobetex, HFEMI07501030P), repeat steps ac, and harvest the crude exosome extract.
[0041] Example 4: Evaluation of the effect of trehalose on exosome yield during exosome isolation.
[0042] a. Add trehalose to 400 mL of cell supernatant to a final concentration of 2%.
[0043] b. The cell supernatant with trehalose added was first filtered through a 1 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS100B015) at a flow rate of 25 mL / min.
[0044] c. The cell supernatant after filtration in step b was further filtered through a 0.22 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS022B015) at a flow rate of 25 mL / min.
[0045] d. The cell supernatant filtered in step c was concentrated to 20-30 mL by TFF, with a flow rate of 100 mL / min and a transmembrane pressure (TMP) of 3 psi. The hollow fiber membrane (Cobetter, HFEMI05001030P) was made of mPES with a surface area of 94 cm 2 , the fiber inner diameter is 1 mm, the molecular weight cutoff is 500 kDa, and the obtained solution is the crude exosome extract.
[0046] Example 5: Evaluate the effect of different filtration times on the purity of exosomes during exosome isolation.
[0047] a. Add trehalose to 400 mL of cell supernatant to a final concentration of 2%. The cell supernatant with trehalose added was first filtered through a 1 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS100B015) at a flow rate of 25 mL / min.
[0048] b. The cell supernatant after filtration in step b was further filtered through a 0.22 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS022B015) at a flow rate of 25 mL / min.
[0049] c. The cell supernatant after filtration in step c was concentrated to 20-30 mL by TFF, with a flow rate of 100 mL / min and a transmembrane pressure TMP of 3 psi. The hollow fiber membrane (Cobetter, HFEMI05001030P) was made of mPES with a surface area of 94 cm 2 , the fiber inner diameter is 1 mm, the molecular weight cutoff is 500 kDa, and the obtained solution is the crude exosome extract.
[0050] d. Add 200 mL of sterile PBS to the crude exosome extract for filtration and concentrate to 20-30 mL by TFF (keep stirring during the concentration process). Then add 200 mL of sterile PBS and repeat this process for 5 times to collect the exosome solution.
[0051] Example 6: Evaluate the effect of composite filler chromatographic separation on the purity of exosomes in exosome isolation.
[0052] a. Add trehalose to 400 mL of cell supernatant to a final concentration of 2%. The cell supernatant with trehalose added was first filtered through a 1 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS100B015) at a flow rate of 25 mL / min.
[0053] b. The cell supernatant after filtration in step b was further filtered through a 0.22 μm PES capsule filter (Shanghai Guanou Purification Technology Co., Ltd., KG60B1PS022B015) at a flow rate of 25 mL / min.
[0054] c. The cell supernatant after filtration in step c was concentrated to 20-30 mL by TFF, with a flow rate of 100 mL / min and a transmembrane pressure TMP of 3 psi. The hollow fiber membrane (Cobetter, HFEMI05001030P) was made of mPES with a surface area of 94 cm 2 , the fiber inner diameter is 1 mm, the molecular weight cutoff is 500 kDa, and the obtained solution is the crude exosome extract.
[0055] d. Add 200 mL of sterile PBS to the crude exosome extract for filtration and concentrate to 20-30 mL by TFF (keep stirring during the concentration process). Then add 200 mL of sterile PBS and repeat this process for 5 times to collect the exosome extract.
[0056] e. The exosome extract obtained in step d was further purified by chromatography using a composite filler (Suzhou Lanxiao Biotechnology Co., Ltd., Seplife® Suncore 700) to obtain a high-purity exosome solution.
[0057] Embodiment 7:
[0058] The exosomes extracted by different methods in Examples 1-6 above were identified, and the results are as follows.
[0059] a. Transmission electron microscopy observation of exosomes. Negative staining method was used to observe exosomes. The brief method is as follows: cut the sealing film and spread it on the laboratory table of the fume hood, take a drop of sample, pure water, and 2% uranyl acetate and drop them on the sealing film respectively, then cover the sample with a copper sheet for 2 minutes, absorb the copper sheet on filter paper, wash it on pure water, absorb the filter paper, place it on the uranium drop for 2 minutes, absorb the uranium with filter paper, and after the copper mesh is dry, place it in the sample box, and take electron microscope photos at 80kV. The transmission electron microscope model used is: HT-7700 (Hitachi). Example 6 The exosomes after tangential flow filtration separation and chromatography separation are respectively as follows Figure 1 and Figure 2 As shown, the classic saucer-shaped structure of exosomes can be observed.
[0060] b. Exosome particle size analysis. Take the frozen exosome samples, thaw them in a 25°C water bath, and place them on ice. Dilute the exosome samples with PBS to a particle concentration of 1.0×10 8 ~5.0×10 9 The particles were in the range of pcs / mL and detected by nanoparticle tracking analyzer (PARTICLE METRIX, ZetaView).
[0061] In Example 1, the number of exosome particles harvested by capsule filters with different surface areas was compared ( Figure 3 , 4.13×10 12 vs 5.39×10 12 ), 450cm 2 Capsule filters with larger surface area are more effective.
[0062] In Example 2, the number of exosome particles harvested by capsule filters of different brands was compared ( Figure 4 , 2.89×10 12 vs5.39×10 12 ), Cobite's capsule filter has better effect.
[0063] In Example 3, the number of exosome particles ( Figure 5 , 2.89×10 12 vs 2.89×10 12 ) and protein amount ( Figure 6 , 204.1mg vs 232.4mg), there was no significant difference in the effect of hollow fiber column 500kDa and 750kDa in separating exosomes.
[0064] The number of exosome particles in Example 4 ( Figure 7 , 2.89×10 12 vs 8.69×10 12 ) comparison showed that the number of exosome particles harvested after trehalose treatment was higher.
[0065] Example 5 Exosome purity ( Figure 8 , 3.34×10 6 vs 8.65×10 7 vs 2.96×10 8 ) compared with the control group, the purity of exosomes increased with the increase of PBS filtration times.
[0066] Example 6 Exosome purity ( Fig. 9 , 3.61×10 7 vs 1.37×10 8 ), the purity of exosomes was further improved after the tangential flow filtration sample was further purified by the composite filler suncore 700.
[0067] Example 8: Anti-inflammatory effect of exosomes derived from human umbilical cord mesenchymal stem cells.
[0068] In order to evaluate whether the human umbilical cord mesenchymal stem cell-derived exosomes prepared as described in Example 6 exhibit anti-inflammatory effects, RAW 264.7 cells were cultured at 3×10 5 Cells were plated in 6 cm culture dishes with 100 cells / well and cultured in complete culture medium containing 1% double antibody and 10% fetal bovine serum. When the cell density was about 80-90%, 1 μg / mL LPS was treated for 24 hours to establish the model (no LPS was added as the negative control group). Exosomes were added at the same time as the model, and the working concentrations were 0μg / mL, 5μg / mL, 10μg / mL, and 20μg / mL, respectively. After 20 hours, cells were collected and the mRNA expression level of pro-inflammatory cytokines (IL-1β) was measured using real-time PCR. GAPDH was used as a reference gene for normalizing the above genes. The primer sequences used in PCR are shown in Table 1 below.
[0069] Table 1: Nucleotide sequences of primers used in real-time PCR:
[0070] Primer name Primer sequences musIL1βqRT F GCCCATCCTCTGTGACTCAT musIL1βqRT R AGGCCACAGGTATTTTGTCG musGAPDH F aggccggtgctgagtatgtc musGAPDH R tgcctgcttcaccaccttct
[0071] The results are as follows Fig.10 As shown, after RAW 264.7 cells were treated with LPS, the mRNA expression level of the pro-inflammatory cytokine IL-1β increased significantly. However, when RAW 264.7 cells were treated with LPS plus the human umbilical cord mesenchymal stem cell-derived exosomes of the present invention, the production of IL-1β was significantly inhibited compared with the model in which RAW 264.7 cells were treated with LPS alone. Therefore, the exosomes of the present invention have excellent anti-inflammatory effects, can inhibit, alleviate or reduce inflammatory responses, and repair damaged skin barrier function.
[0072] Example 9: Anti-aging effect of exosomes derived from human umbilical cord mesenchymal stem cells.
[0073] In order to evaluate whether the human umbilical cord mesenchymal stem cell-derived exosomes prepared as described in Example 6 exhibit anti-aging effects, cell viability was detected by CCK8, and the expression of type I collagen Α1 (COL-1A1) was detected by Western Blot.
[0074] Cell viability test: Human skin fibroblasts (HSF) were seeded in 96-well plates at 5,000 cells / well. After the cells adhered to the plate, they were irradiated with UVA. Specifically, the UV light source was 15 cm away from the cells and the radiation intensity was 2 mW / cm 2, the irradiation time was 1400s. After modeling, the old culture medium was discarded, and complete culture medium with or without exosomes was added to treat the cells for 72h. The working concentrations of exosomes were 5μg / mL, 10μg / mL, and 20μg / mL, respectively. Cells irradiated only with UV were used as positive controls, and cells not irradiated with UV were used as negative controls. After 72h, CCK8 reagent was added for cell viability detection, and the OD450 value was read within 2h.
[0075] Western Blot detection: Human skin fibroblasts (HSF) were cultured at 3×10 5 The cells were plated in 6 cm culture dishes and irradiated with UVA after they adhered to the wall. Specifically, the UV light source was 15 cm away from the cells and the radiation intensity was 2 mW / cm 2 , the irradiation time was 1400s. After modeling, the old culture medium was removed, and complete culture medium containing or without exosomes was added to treat the cells for 72h. The working concentrations of exosomes were 5μg / mL, 10μg / mL, and 20μg / mL, respectively. Cells irradiated with UV alone were used as positive controls, and cells without UV irradiation were used as negative controls. After 72h, cells were collected and type I collagen Α1 (COL-1A1) was detected by Western Blot.
[0076] The results are as follows Fig.11 and 12 As shown in the figure, after HSF cells were treated with UV irradiation, cell viability decreased, COL-1A1 protein expression level decreased, and cells were damaged. However, after adding exosomes and co-incubating for 72 hours, HSF cell viability increased ( Fig.11 ), COL-1A1 protein levels returned to normal ( Fig.12 ), therefore, the exosomes of the present invention have the effects of promoting collagen synthesis in human skin fibroblasts, removing wrinkles and anti-aging.
[0077] Example 10: Evaluation of the skin regeneration effect of human umbilical cord mesenchymal stem cell-derived exosomes on human dermal fibroblasts.
[0078] To evaluate whether human umbilical cord mesenchymal stem cell-derived exosomes prepared as described in Example 6 promote wound healing of human dermal fibroblasts (HSFs), a scratch-wound assay was performed.
[0079] Scratch-wound test: First, use a marker pen to draw vertical lines on the back of a 6-well plate with a ruler, one for each well, and divide the vertical lines into three equal parts for marking. Human dermal fibroblasts dispersed in DMEM containing fetal bovine serum were cultured at a rate of 7×10 5Cells were inoculated into wound induction culture plates (ImageLock plates; purchased from EssenBio) at a density of 10 cells / well and cultured at 5% CO2 and 37°C for 24 hours. After the cells reached a confluence of 90% or higher, scratches were made using Wound Maker, the cells were washed 3 times with PBS, the scratched cells were removed, serum-free culture medium and exosomes were added, and the working concentrations of exosomes were 0μg / mL, 5μg / mL, 10μg / mL, and 20μg / mL, respectively. The cells were placed in a 37°C, 5% CO2 incubator for 0 hours, and photographed after 24 hours to detect the migration ability of the cells.
[0080] The results are as follows Fig.13 As shown, compared with the control group, the exosome group significantly increased the migration of human dermal fibroblasts, indicating that the human umbilical cord mesenchymal stem cell-derived exosomes of the present invention have an excellent effect of promoting the migration of human dermal fibroblasts and can be used to heal wounds.
[0081] The technical features disclosed above are not limited to the disclosed combinations with other features. Those skilled in the art may also make other combinations between the technical features according to the purpose of the invention to achieve the purpose of the invention.
Claims
1. A method for large-scale isolation of exosomes, characterized in that: Step 1: Take the cell supernatant to be separated and add trehalose, first pass through two-stage filtration, then pass through hollow fiber membrane circulation concentration to obtain the exosome crude extract; Step 2: The crude exosome extract was replaced and filtered with phosphate buffered saline (PBS) to remove small molecule impurities; Step 3: Further purify through composite filler chromatography to obtain a high-purity exosome solution.
2. The method according to claim 1, characterized in that In step 1, the cell supernatant contains trehalose and is concentrated by tangential flow filtration (TFF).
3. The method according to claim 1, characterized in that In step 2, the phosphate buffer contains trehalose, and the replacement and filtration are performed 5 times, with the best effect.
4. The method according to claim 1, characterized in that: In step 3, the exosomes flow through the column in the form of flow-through and flow out before the impurity molecules.
5. The method according to any one of claims 1 to 3, characterized in that: The trehalose concentration was 2% w / v.
6. Exosomes prepared by the method according to any one of claims 1 to 6.
7. Use of the exosomes as claimed in claim 7 in skin anti-inflammatory, anti-aging and repair.
